Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. ROIV
6. ORCL
7. AAPL
8. HOOD
9. NVDA
10. USO

Go back to Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
Gilead Sciences (NASDAQ: GILD) Delayed: 146.67 -4.33 (2.87%)
Previous Close $151.00    52 Week High $108.63 
Open $146.98    52 Week Low $71.39 
Day High $148.65    P/E 81.03 
Day Low $145.45    EPS $1.81 
Volume 788,656       

(NYSE: RCUS) Delayed: 29.20 -0.46 (1.55%)
Previous Close $29.66    52 Week High $ 
Open $29.21    52 Week Low $ 
Day High $29.49    P/E N/A 
Day Low $28.79    EPS $ 
Volume 177,426